Blog | Gen Re

Our Perspective

Progress in the Management of Multiple Sclerosis

By Dr. Chris Ball |November 23, 2017|English

Multiple Sclerosis (MS) presents a challenge to insurers due to its complex, unpredictable course. MS is a covered condition in “Critical Illness” insurance policies sold in markets across Asia, in the UK and Ireland, South Africa, New Zealand...
Read More
Genetic Testing and the Power of Knowledge

By Annika Schilling |November 16, 2017|English

Using genetic testing to make treatment decisions on serious medical conditions, such as cancer, is becoming more common. Approved tests number in the thousands, and the costs associated with genome sequencing have fallen sharply. Most genetic tests...
Read More
Opportunity Is Knocking - Will You Answer?

By Steve Rowley|November 13, 2017|English

Gen Re has just completed our 16th annual U.S. Critical Illness Market Survey. The data gathered from 53 participating carriers captures a moment-in-time snapshot of where the market is today. This snapshot comes to life when we look to the historical...
Read More
How Deep Brain Stimulation Helps Manage Neurological Disorders

By Dr. Chris Ball |October 24, 2017|English

Using electrical stimulation to manage brain disorders has a long and chequered history. Deep Brain Stimulation (DBS) is the latest. It involves implanting electrodes, connected to a computerized pulse generator, deep into the structure of the brain....
Read More
Advances in Medical Diagnosis and Treatment - Risk or Opportunity for Critical Illness Insurance?

By Steve Rowley|October 10, 2017|English

Medicine is changing - but what that means to patients and insurers could mean very different things. Even within our world of insurance, the answer will vary by product. Will rapid advancements in cancer diagnosis and treatment mean greater profits...
Read More
New Diagnostics and a Future for Critical Illness Insurance

By Ross Campbell |October 05, 2017|English

Millions have benefitted from the cushion Critical Illness (CI) products provide to financial hardship linked to a cancer diagnosis, stroke or heart attack. CI has also been rewarding for providers, not just by helping them remain relevant but by also...
Read More